TITLE
Double-knockout p53/PRKDC model of B cell acute lymphoblastic leukemia: leukemic blasts

SUMMARY
Analysis of leukemic blasts from p53/Prkdc double-knockout mutants that spontaneously develop early B cell acute lymphoblastic leukemia (B-ALL). Results provide insight into molecular mechanisms underlying high-risk B-ALL.

ORGANISM
Mus musculus

PLATFORM
GPL1261 : [Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array

CITATIONS
Perova T, Grandal I, Nutter LM, Papp E et al. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia. Sci Transl Med 2014 May 14;6(236):236ra62. PMID:Â  24828076

